![]()
侯旭奔
-
副教授
博士生导师
硕士生导师
- 性别：男
- 出生日期：1990-03-22
- 毕业院校：山东大学
- 学历：研究生(博士后)
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2018-12-18
- 学科：药物化学
- 办公地点：趵突泉校区景蓝斋
大学科技园3号楼1514室
- 联系方式：hxb@email.sdu.edu.cn
- 电子邮箱：hxb@email.sdu.edu.cn
访问量：
-
[1]
Liu, Meng.
Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis an.
Journal of Medicianal Chemistry,
2024.
-
[2]
邱雪婷.
An in-line method for high-throughput screening of protein tyrosine phosphatase receptor type O inhi.
Journal of chromatography A,
1713,
2024.
-
[3]
.
Interaction of PKR with STCS1: an indispensable step in the biosynthesis of lunularic acid in <i>Mar.
New Phytologist,
237,
515,
2023.
-
[4]
.
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibit.
EUR J MED CHEM,
2023.
-
[5]
.
沙门氏菌III型分泌系统抗感染类抑制剂的筛选.
微生物学通报,
50,
1-20,
2023.
-
[6]
.
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to trea.
CELL CHEMICAL BIOLOGY,
30,
553-568.e7,
2023.
-
[7]
聂义明.
Development of QSRR model for hydroxamic acids using PCA-GA-BP algorithm incorporated with molecular.
FRONTIERS IN CHEMISTRY,
2022.
-
[8]
.
Structural basis of human SNAPc recognizing proximal sequence element of snRNA promoter.
NATURE COMMUNICATIONS,
2022.
-
[9]
.
Structural insight into TIPE1 functioning as a lipid transfer protein.
JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS,
2023.
-
[10]
Liang, Xiao.
Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors.
Bioorganic Chemistry,
121,
105643,
2022.
-
[11]
侯旭奔.
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhib.
Journal of Medicinal Chemistry,
2022.
-
[12]
侯旭奔.
PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer.
Journal of Cancer,
12,
7445-7453,
2021.
-
[13]
梁翰之.
Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Ca.
FRONT PHARMACOL,
13,
864342,
2022.
-
[14]
陈晨.
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antit.
Journal of Medicinal Chemistry,
65,
3667,
2022.
-
[15]
刘蒙.
Strategies to overcome drug resistance using SHP2 inhibitors.
ACTA PHARMACEUTICA SINICA B,
11,
3908,
2021.
-
[16]
刘璐璐.
Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
191,
2020.
-
[17]
孙金鹏 , 方浩 and 侯旭奔.
Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed c.
EUR J MED CHEM,
190,
2020.
-
[18]
杜金童.
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibi.
Future Medicinal Chemistry,
12,
1293,
2020.
-
[19]
梁涛.
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivativ.
European Journal of Medicinal Chemistry,
221,
2021.
-
[20]
李雯.
Photopharmacology-based small-molecule proteolysis targeting chimeras: optical control of protein de.
Future Medicinal Chemistry,
12,
1991,
2020.
